New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 10, 2013
07:41 EDTDGXQuest Diagnostics downgraded at BofA/Merrill
As previously reported, BofA/Merrill downgraded Quest Diagnostics to Underperform from Buy. The firm downgraded shares due to a weak growth outlook, deal strategy changes, and impact from cost cutting program. Price target lowered to $55 from $64.
News For DGX From The Last 14 Days
Check below for free stories on DGX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for DGX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use